{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:43:54Z","timestamp":1774629834378,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.pcad.2022.08.007","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T01:17:15Z","timestamp":1661649435000},"page":"78-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA\/ACC\/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey"],"prefix":"10.1016","volume":"75","author":[{"given":"Kartik","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya S.","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vardhmaan","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Al Rifai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro","family":"Slipczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Nambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil J.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.pcad.2022.08.007_bb0010","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation."},{"issue":"24","key":"10.1016\/j.pcad.2022.08.007_bb0015","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.jacc.2018.11.005","article-title":"Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology","volume":"73","author":"Lloyd-Jones","year":"2019","journal-title":"J Am Coll Cardiol."},{"issue":"11","key":"10.1016\/j.pcad.2022.08.007_bb0020","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.pcad.2022.08.007_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11883-019-0776-8","article-title":"Cholesterol Guidelines: Key Topics in Primary Prevention","volume":"21","author":"Clark","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.pcad.2022.08.007_bb0030","series-title":"National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol)","author":"Centers for Disease Control and Prevention (CDC)","year":"2021"},{"issue":"Supplement_1","key":"10.1016\/j.pcad.2022.08.007_bb0035","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u20142022","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2021","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.pcad.2022.08.007_bb0040","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol."},{"issue":"7","key":"10.1016\/j.pcad.2022.08.007_bb0045","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.mayocp.2020.11.027","article-title":"Relative predictive value of circulating immune markers in US adults without cardiovascular disease: implications for risk reclassification","volume":"96","author":"Gupta","year":"2021","journal-title":"Mayo Clin Proc."},{"issue":"25 Suppl 2","key":"10.1016\/j.pcad.2022.08.007_bb0050","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2022.08.007_bb0055","series-title":"NHANES Analytic Guidance and Brief Overview for the 2017-March 2020 Pre-pandemic Data Files","year":"2021"},{"issue":"17","key":"10.1016\/j.pcad.2022.08.007_bb0060","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/CIRCULATIONAHA.121.057889","article-title":"Temporal trends in the remaining lifetime risk of cardiovascular disease among middle-aged adults across 6 decades: the framingham study","volume":"145","author":"Vasan","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2022.08.007_bb0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jamacardio.2016.0991","article-title":"Risk of premature cardiovascular disease vs the number of premature cardiovascular events","volume":"1","author":"Sniderman","year":"2016","journal-title":"JAMA Cardiology."},{"issue":"24","key":"10.1016\/j.pcad.2022.08.007_bb0070","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus","volume":"133","author":"Wang","year":"2016","journal-title":"Circulation."},{"issue":"9733","key":"10.1016\/j.pcad.2022.08.007_bb0075","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet."},{"issue":"12","key":"10.1016\/j.pcad.2022.08.007_bb0080","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jacc.2016.06.048","article-title":"Practice-level variation in;statin use among patients with diabetes","volume":"68","author":"Pokharel","year":"2016","journal-title":"Journal of the American College of Cardiology."},{"issue":"19","key":"10.1016\/j.pcad.2022.08.007_bb0085","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: us preventive services task force recommendation statement","volume":"316","author":"Force","year":"2016","journal-title":"JAMA."},{"issue":"15","key":"10.1016\/j.pcad.2022.08.007_bb0090","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/jama.2017.3416","article-title":"Comparison of recommended eligibility for primary prevention statin therapy based on the us preventive services task force recommendations vs the ACC\/AHA guidelines","volume":"317","author":"Pagidipati","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2022.08.007_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwac161","article-title":"Temporal trends in atherosclerotic cardiovascular disease risk among U.S. adults. Analysis of the National Health and Nutrition Examination Survey (NHANES), 1999\u20132018","author":"Chobufo","year":"2022","journal-title":"Eur J Prev Cardiol."}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062022000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062022000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:20:29Z","timestamp":1758500429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062022000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":18,"alternative-id":["S0033062022000962"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2022.08.007","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA\/ACC\/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2022.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}